8,700 Studies Reviewed. 87.0% Found Biological Effects. The Evidence is Clear.

Manville, II, Ph

Bioeffects Seen

Authors not listed · 2016

Share:

Environmental conditions fundamentally alter how substances interact with biological systems, a principle crucial for understanding EMF health effects.

Plain English Summary

Summary written for general audiences

This study examined how pH levels affect the solubility and dissolution of carvedilol, a heart medication that belongs to a class of drugs with low water solubility. Researchers found that carvedilol dissolves much better in acidic conditions (like stomach acid) compared to neutral pH environments (like intestinal fluid). This research helps pharmaceutical scientists understand how drug absorption varies throughout the digestive system.

Why This Matters

While this pharmaceutical study doesn't directly address EMF health effects, it demonstrates an important principle that applies to EMF research: how environmental conditions dramatically alter biological responses. Just as carvedilol's effectiveness depends entirely on pH levels in different parts of the digestive system, EMF effects on human biology can vary dramatically based on frequency, duration, power levels, and individual physiological conditions. The pharmaceutical industry has learned to account for these variables when developing medications, yet the wireless industry often ignores similar biological complexity when claiming EMF safety. This study's rigorous methodology for testing multiple environmental conditions offers a model for how EMF research should be conducted - examining not just whether effects occur, but under what specific conditions they're most pronounced.

Exposure Information

Specific exposure levels were not quantified in this study.

Cite This Study
Unknown (2016). Manville, II, Ph.
Show BibTeX
@article{manville_ii_ph_ce4898,
  author = {Unknown},
  title = {Manville, II, Ph},
  year = {2016},
  doi = {10.1208/s12249-015-0365-2},
  
}

Quick Questions About This Study

Carvedilol is a heart medication classified as BCS Class II, meaning it has low water solubility but high permeability. Studying its pH-dependent behavior helps predict how well the drug will be absorbed in different parts of the digestive system.
Carvedilol showed dramatically higher solubility in acidic conditions (545-2591 μg/mL at pH 1.2-5.0) compared to neutral pH (only 5.8-51.9 μg/mL at pH 6.5-7.8), representing up to a 400-fold difference in solubility.
BCS Class II drugs have low solubility but high permeability, meaning they don't dissolve easily in water but can cross biological membranes well once dissolved. This makes their absorption highly dependent on dissolution conditions.
Lower buffer capacity resulted in decreased carvedilol solubility and slower dissolution rates. Buffer capacity refers to a solution's ability to resist pH changes, affecting how consistently the drug dissolves over time.
In acidic gastric-like conditions (pH 1.2-5.0), carvedilol achieved nearly complete dissolution (95.8-98.2% within 60 minutes). In neutral intestinal-like conditions (pH 6.5-7.8), dissolution was much lower (15.9-86.2% within 240 minutes).